| Ann Christine Still, MD | |
|
1701 Main Ave Sw, Suite E, Cullman, AL 35055-5299 | |
| (256) 531-9213 | |
| (256) 841-6019 |
| Full Name | Ann Christine Still |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 37 Years |
| Location | 1701 Main Ave Sw, Cullman, Alabama |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811977135 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Impact Healthcare, Pllc | 5991065427 | 8 |
News Archive
SAS, the leader in business analytics software and services and the de facto industry standard for clinical data analysis and reporting in the life sciences/pharmaceutical industry, today expanded its Global Certification Program offerings with the introduction of a new credential - SAS Certified Clinical Trials Programmer using SAS9.
The monoclonal antibody mepolizumab has been approved since the end of 2015 for the treatment of adults with severe refractory eosinophilic asthma. The German Institute for Quality and Efficiency in Health Care now examined in an early benefit assessment whether the drug offers an added benefit for patients in comparison with the appropriate comparator therapy.
Daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.
On Sunday, April 28, a team of researchers received the 2019 Human Growth Award at the Pediatric Endocrine Society's Annual Meeting for their abstract, entitled "Clinical Characterization and Trial of Growth Hormone in Patients with Aggrecan Deficiency: 6 Month Data," and presented this at the PES Presidential Poster Session.
Genetic sequencing technology is altering the way cancer is diagnosed and treated, but traditional specimen handling methods threaten to slow that progress.
› Verified 7 days ago
| Entity Name | Spectrum Pain Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265533897 PECOS PAC ID: 4183538887 Enrollment ID: O20031117000830 |
News Archive
SAS, the leader in business analytics software and services and the de facto industry standard for clinical data analysis and reporting in the life sciences/pharmaceutical industry, today expanded its Global Certification Program offerings with the introduction of a new credential - SAS Certified Clinical Trials Programmer using SAS9.
The monoclonal antibody mepolizumab has been approved since the end of 2015 for the treatment of adults with severe refractory eosinophilic asthma. The German Institute for Quality and Efficiency in Health Care now examined in an early benefit assessment whether the drug offers an added benefit for patients in comparison with the appropriate comparator therapy.
Daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.
On Sunday, April 28, a team of researchers received the 2019 Human Growth Award at the Pediatric Endocrine Society's Annual Meeting for their abstract, entitled "Clinical Characterization and Trial of Growth Hormone in Patients with Aggrecan Deficiency: 6 Month Data," and presented this at the PES Presidential Poster Session.
Genetic sequencing technology is altering the way cancer is diagnosed and treated, but traditional specimen handling methods threaten to slow that progress.
› Verified 7 days ago
| Entity Name | Impact Healthcare, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487185153 PECOS PAC ID: 5991065427 Enrollment ID: O20180201001424 |
News Archive
SAS, the leader in business analytics software and services and the de facto industry standard for clinical data analysis and reporting in the life sciences/pharmaceutical industry, today expanded its Global Certification Program offerings with the introduction of a new credential - SAS Certified Clinical Trials Programmer using SAS9.
The monoclonal antibody mepolizumab has been approved since the end of 2015 for the treatment of adults with severe refractory eosinophilic asthma. The German Institute for Quality and Efficiency in Health Care now examined in an early benefit assessment whether the drug offers an added benefit for patients in comparison with the appropriate comparator therapy.
Daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.
On Sunday, April 28, a team of researchers received the 2019 Human Growth Award at the Pediatric Endocrine Society's Annual Meeting for their abstract, entitled "Clinical Characterization and Trial of Growth Hormone in Patients with Aggrecan Deficiency: 6 Month Data," and presented this at the PES Presidential Poster Session.
Genetic sequencing technology is altering the way cancer is diagnosed and treated, but traditional specimen handling methods threaten to slow that progress.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ann Christine Still, MD 22454 Us Highway 72, Ste 310, Athens, AL 35613-2609 Ph: (256) 882-2003 | Ann Christine Still, MD 1701 Main Ave Sw, Suite E, Cullman, AL 35055-5299 Ph: (256) 531-9213 |
News Archive
SAS, the leader in business analytics software and services and the de facto industry standard for clinical data analysis and reporting in the life sciences/pharmaceutical industry, today expanded its Global Certification Program offerings with the introduction of a new credential - SAS Certified Clinical Trials Programmer using SAS9.
The monoclonal antibody mepolizumab has been approved since the end of 2015 for the treatment of adults with severe refractory eosinophilic asthma. The German Institute for Quality and Efficiency in Health Care now examined in an early benefit assessment whether the drug offers an added benefit for patients in comparison with the appropriate comparator therapy.
Daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.
On Sunday, April 28, a team of researchers received the 2019 Human Growth Award at the Pediatric Endocrine Society's Annual Meeting for their abstract, entitled "Clinical Characterization and Trial of Growth Hormone in Patients with Aggrecan Deficiency: 6 Month Data," and presented this at the PES Presidential Poster Session.
Genetic sequencing technology is altering the way cancer is diagnosed and treated, but traditional specimen handling methods threaten to slow that progress.
› Verified 7 days ago
Christopher D Coccia, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 408 Clark St Ne, Cullman, AL 35055 Phone: 256-734-3202 Fax: 256-734-4668 | |
Thomas W Montgomery, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 408 Clark St Ne, Cullman, AL 35055 Phone: 256-734-3202 Fax: 256-734-4668 | |
Tyler James Rushforth, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1935 Alabama Highway 157, Suite C, Cullman, AL 35058 Phone: 256-297-3030 Fax: 256-297-3301 | |
Lauren C Robinson, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1948 Al Highway 157 Ste 450, Cullman, AL 35058 Phone: 256-735-5075 Fax: 256-962-5598 | |
Justin Rushing, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1750 Al Highway 157, Cullman, AL 35058 Phone: 256-427-2427 | |
Michael L Schendel, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 408 Clark St Ne, Cullman, AL 35055 Phone: 256-734-3202 Fax: 256-734-4668 | |
Dr. Patrick S. Baldwin, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1912 Alabama Highway 157, Cullman, AL 35055 Phone: 256-737-2100 |